Antipsychotics - For a Healthy Belgium

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	56.74%
INSURED CONSUMERS
% of insured consumers	3.25%
Median age	58 years
Max/min ratio of the median age (by district)	1.13
Percentage of women	55.24%
Ratio Preferential scheme/General scheme	3.56
Coefficient of variation (2022)	13.25
Max/min ratio of % of insured consumers (by district)	1.61
CONSUMPTION
Annual consumption (DDD)	55,740,241
Consumption of DDD (per 100,000 insured persons)	484,322.92
% DDD issued outside the insurance (approximate)	3.31%
Average annual consumption per insured consumer (DDD)	148.81
% of insured consumers with > 3 times the average consumption	8,26%
Coefficient of variation 2013-2015	14.84
Coefficient of variation 2020-2022	15.23
Trend 2013-2022	0.43%
Trend 2013-2019	-0.05%
Trend 2019-2022	1.38%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	79,655,309€
Average annual expenditure per insured person	6.92 €
Average patient share per insured consumer	11.74%
Max/min ratio of expenditure per insured person (by disctrict)	2.10
% “Low-cost” medication	71.90%
Trend 2013-2022	-4.03%
Trend 2019-2022	-3.28%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES (ATC-5)	LABELS
N05AA	PHENOTHIAZINES WITH ALIPHATIC SIDE-CHAIN
N05AD	BUTYROPHENONE DERIVATIVES
N05AE	INDOLE DERIVATIVES
N05AF	THIOXANTHENE DERIVATIVES
N05AG	DIPHENYLBUTYLPIPERIDINE DERIVATIVES
N05AH	DIAZEPINES, OXAZEPINES, THIAZEPINES AND OXEPINES
N05AL	BENZAMIDES
N05AN	LITHIUM
N05AX	OTHER ANTIPSYCHOTICS